Search research articles
Contact Us
Filters
Showing results (91-100 of 251) with videos related to
Page
of 26
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
October 27, 2016
Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma
Hugo J A Adams, Thomas C Kwee
Pediatric Hematology and Oncology
|
February 23, 2016
Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
June 1, 2016
Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
Hugo J A Adams, Thomas C Kwee
Seminars in Nuclear Medicine
|
June 7, 2017
Guest Editorial on PET of Benign Musculoskeletal Conditions
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2020
Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
June 14, 2015
Negative PET: no guarantee of good prognosis in Hodgkin's lymphoma
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2018
Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma
Hugo J A Adams, Thomas C Kwee
Haematologica
|
August 2, 2018
Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma
Hugo J A Adams, Thomas C Kwee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Letter
Hugo J A Adams, Thomas C Kwee
Acta Oncologica (Stockholm, Sweden)
|
February 22, 2018
Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?
Hugo J A Adams, Thomas C Kwee
Page
of 26
Search research articles
Search
Showing results (91-100 of 251) with videos related to
Sort By:
Page
of 26
European Journal of Nuclear Medicine and Molecular Imaging
|
October 27, 2016
Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma
Hugo J A Adams, Thomas C Kwee
Pediatric Hematology and Oncology
|
February 23, 2016
Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
June 1, 2016
Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
Hugo J A Adams, Thomas C Kwee
Seminars in Nuclear Medicine
|
June 7, 2017
Guest Editorial on PET of Benign Musculoskeletal Conditions
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 31, 2020
Inability of Fluorodeoxyglucose Positron Emission Tomography to Detect Viable Hodgkin Lymphoma During and After Treatment
Hugo J A Adams, Thomas C Kwee
Annals of Hematology
|
June 14, 2015
Negative PET: no guarantee of good prognosis in Hodgkin's lymphoma
Hugo J A Adams, Thomas C Kwee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2018
Unproven Clinical Value of Interim FDG-PET in Aggressive Non-Hodgkin Lymphoma
Hugo J A Adams, Thomas C Kwee
Haematologica
|
August 2, 2018
Unproven value of end-of-treatment and serial follow-up FDG-PET in primary mediastinal B-cell lymphoma
Hugo J A Adams, Thomas C Kwee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Letter
Hugo J A Adams, Thomas C Kwee
Acta Oncologica (Stockholm, Sweden)
|
February 22, 2018
Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?
Hugo J A Adams, Thomas C Kwee
Page
of 26